Phthalic Anhydride Exposure Limits: What Paint and Coating Manufacturers Need to Know Before TSCA Finalization

If your facility manufactures or processes solvent-based paints, coatings, plastics, or adhesives, phthalic anhydride is part of your supply chain. It’s a strong respiratory sensitizer—meaning workers exposed to it can develop occupational asthma, even at levels below OSHA’s permissible exposure limit.

⚡ TL;DR: EPA just found phthalic anhydride presents “unreasonable risk” to workers—restrictions coming 2026–2027. OSHA allows 1 ppm; ACGIH recommends 0.0003 ppm (500x more protective). OSHA compliance ≠ worker safety. If you haven’t baseline-sampled your facility’s exposure, you’re unprepared for EPA’s final rule. Paint/coating manufacturers should start reformulation testing now.

The stakes just got higher. In 2026, the EPA released a draft risk evaluation finding that phthalic anhydride presents an “unreasonable risk” to workers and consumers. This signals incoming restrictions—potentially through labeling, manufacturing limits, or use restrictions—within the next 12–18 months.

⚠️ Why This Crisis Is Real: OSHA compliance doesn’t mean safety. Your workers can be “legal” under OSHA’s 1 ppm PEL and still develop respiratory sensitization. Once sensitized, that worker can never return to phthalic anhydride exposure without symptoms—a career-ending hazard. EPA’s “unreasonable risk” language means restrictions are coming, and manufacturers who wait until late 2026 for EPA’s final rule will scramble in a compressed timeline with limited reformulation options.

The Regulatory Landscape: OSHA PEL vs. ACGIH TLV (And Why They Don’t Align)

OSHA’s permissible exposure limit (PEL) for phthalic anhydride is straightforward: 1 ppm (6 mg/m³) as an 8-hour time-weighted average. That’s the enforceable standard. If your workers’ exposure stays below that threshold, you’re compliant with federal law.

But compliance with OSHA doesn’t mean safety.

The American Conference of Governmental Industrial Hygienists (ACGIH) published a far more stringent recommendation in 2024. Their threshold limit value (TLV) for phthalic anhydride is 0.002 mg/m³ (0.0003 ppm) as a TWA, with a short-term exposure limit (STEL) of 0.005 mg/m³. There’s also a skin level limit of 0.05 mg/100 cm² because dermal exposure matters here.

That’s roughly 500 times more protective than OSHA’s PEL.

Why the gap? OSHA’s PEL for phthalic anhydride was set in 1989 and hasn’t been updated since. Industrial hygiene science has advanced significantly. The newer evidence shows that phthalic anhydride’s sensitization risk is dose-dependent and individual—some workers develop respiratory sensitivity at lower exposures than others. The ACGIH standard reflects that.

The point: Your facility might be “OSHA compliant” and still exposing workers to levels that safety experts consider hazardous.

Why This Matters Now: The EPA’s TSCA Risk Evaluation

Here’s what changed in 2026.

The EPA, under the Toxic Substances Control Act, is conducting a formal risk evaluation of phthalic anhydride. In early 2026, they released a draft evaluation. The conclusion: phthalic anhydride presents an unreasonable risk to workers through inhalation and dermal exposure in manufacturing, processing, and commercial conditions. It also poses unreasonable risk to consumers through dermal and inhalation exposure in solvent-based paints, coatings, adhesives, and sealants.

That language—“unreasonable risk”—is regulatory shorthand for “we’re going to restrict this.”

The next steps are clear: EPA is holding a Significant New Use Rule (SNUR) and risk management decision in June 2026, with a formal 60-day public comment period. By late 2026 or early 2027, expect EPA to issue restrictions. These could include:

Manufacturing or processing limits
Use restrictions (especially for consumer-facing products like solvent-based paints)
Labeling requirement updates
Occupational health monitoring mandates

For paint and coating manufacturers, this means compliance action is coming whether OSHA updates its PEL or not.

Who’s Actually at Risk?

If you’re in one of these industries, pay attention:

Paint and Coating Manufacturers (SIC 2851) Solvent-based paints, lacquers, and finishes are where phthalic anhydride concentration is highest. Workers mixing formulations, handling raw materials, and conducting quality checks face the greatest exposure.

Plastic Resin Producers (SIC 2821) PVC production, unsaturated polyester resin manufacturing—these operations use phthalic anhydride as a feedstock. Workers in reactors, curing areas, and packing operations experience routine exposure.

Chemical Manufacturers (SIC 2865, SIC 2869) If you’re producing cyclic organic compounds or industrial organic chemicals, phthalic anhydride is likely part of your portfolio. Manufacturing facilities have the highest exposure variability.

Adhesive and Sealant Manufacturers (SIC 2891) Many polyester-based adhesives and sealants incorporate phthalic anhydride. Workers in formulation and filling operations experience chronic low-level exposure.

The risk isn’t just about exposure levels. It’s about sensitization. The NIOSH Immediately Dangerous to Life or Health (IDLH) level is 60 mg/m³—but long before reaching that acute hazard level, workers can develop occupational asthma or respiratory sensitization from chronic exposure at much lower concentrations. That sensitization is permanent. Once a worker is sensitized to phthalic anhydride, even trace exposure can trigger symptoms.

What Respiratory Sensitization Actually Looks Like

This is where the blind spot usually lives.

A worker doesn’t “fail” an exposure limit and then get asthma. Sensitization develops gradually. In the first weeks or months of exposure, a worker may notice:

Cough or throat irritation that doesn’t resolve after shifts end
Shortness of breath during or after work activities
Nasal congestion or sinus irritation
Skin reactions at contact sites

If exposure continues, true occupational asthma can develop—characterized by reversible airway obstruction, wheeze, chest tightness, and breathing difficulty. The irony: by the time the asthma is recognized, the sensitization is permanent. The worker can never return to phthalic anhydride exposure without symptoms.

Most facilities catch this too late. Workers self-treat symptoms or attribute them to allergies. By the time occupational health surveillance (if it exists) picks it up, the facility has a liability issue and the worker has a career problem.

Current Compliance Requirements: What You Have to Do Today

Under OSHA, your facility must:

Monitor worker exposure using OSHA Method 90 or equivalent sampling and analysis. If your facility handles phthalic anhydride, you need baseline exposure data. If you haven’t documented exposure levels, that’s a compliance gap right now.
Maintain exposure below the 1 ppm PEL. This typically requires engineering controls: local exhaust ventilation (LEV) at mixing areas, process isolation, or closed-loop transfer systems for solid materials. PPE alone (respirators) is not acceptable as a primary control—it’s supplemental.
Implement hazard communication that labels products containing phthalic anhydride with sensitizer warnings and provides Safety Data Sheets to workers and distributors. Your current SDS must clearly identify phthalic anhydride as a respiratory and dermal sensitizer.
Provide respiratory protection (NIOSH-approved respirators) where engineering controls are insufficient. Workers must be fit-tested and trained annually.
Document and train. Workers with potential exposure need training on the sensitization hazard and recognition of early symptoms. Your facility should have written procedures for handling phthalic anhydride.

That’s the current baseline. Compliance audits often reveal gaps in exposure monitoring—many facilities have never quantified their workers’ exposure. That’s a red flag for OSHA and will be a red flag for EPA once the TSCA rule is finalized.

Preparing for TSCA Finalization: A Three-Step Roadmap

The EPA’s risk evaluation is in the public comment and peer review phase through June 2026. By late 2026 or early 2027, expect a final rule. Here’s how to prepare:

Step 1: Document Your Current Exposure Profile Run full-shift air sampling (8-hour TWA) in all areas where phthalic anhydride is handled. Include mixing areas, reactors, packing, and quality control labs. Get a hygienist-led exposure assessment if you haven’t done one in the past 2 years. You need baseline data before EPA issues restrictions—it will determine which compliance tier you fall into under the new rule.

Step 2: Assess Your Formulations and Processes If you’re a paint or coating manufacturer, conduct a formulation audit. Which products contain phthalic anhydride? Which can be reformulated? Which are specialty products with no substitutes? This inventory will inform your compliance strategy. Some manufacturers are already developing phthalic anhydride-free alternatives in anticipation of restrictions.

Step 3: Strengthen Your Worker Surveillance Implement baseline and periodic respiratory health monitoring for workers with potential exposure. This doesn’t have to be expensive—baseline spirometry and annual follow-up testing costs $300–$500 per worker per year and creates a documented record of worker health status. If EPA’s rule includes medical surveillance as a requirement, you’ll already be ahead.

What EPA’s “Unreasonable Risk” Decision Means for Your Timeline

EPA’s language is important. “Unreasonable risk” is not the same as “we’re banning this chemical.” It means EPA has determined that the current conditions of use—manufacturing, processing, industrial exposure, and consumer exposure in paints/coatings—create unacceptable risk to workers and consumers.

The risk management options EPA typically considers:

Labeling and hazard communication changes (likely—expect stronger “Respiratory Sensitizer” warnings)
Manufacturing/processing restrictions (possible—phase-out of certain uses or manufacturing conditions)
Consumer product restrictions (likely for solvent-based paints and coatings)
Occupational health monitoring requirements (likely for worker protection)

For manufacturers in the industrial supply chain (resins, feedstock chemicals), restrictions may focus on use limits or mandatory worker health programs. For paint and coating manufacturers serving consumers, product reformulation or restricted distribution channels are possible.

The timeline: EPA will issue a proposed rule in 2026, accept comments, and likely finalize restrictions by mid-to-late 2027. That gives you about 12–18 months to assess, document, and prepare.

What to do this month: Pull your air sampling data (or schedule sampling if you’ve never done baseline exposure monitoring). Get baseline respiratory health on your affected workers. Review your product formulations. Manufacturers who have documented their current exposure profile and identified reformulation pathways by mid-2026 will face far fewer compliance surprises when EPA’s final rule drops.

A Practical Next Step

If your facility manufactures or processes phthalic anhydride-containing products, you have three immediate actions:

Pull your exposure monitoring data. If you don’t have recent air sampling results showing worker exposure levels, schedule one now. That baseline is your starting point for understanding compliance readiness.
Review your Safety Data Sheets for accuracy on sensitization hazards and current control measures. If your SDS is more than 2 years old or doesn’t emphasize respiratory sensitization risk, update it.
Connect with your industrial hygiene partner or occupational health consultant to map out your exposure control hierarchy: Are you relying too heavily on PPE? Can your engineering controls be improved? Do you have adequate medical surveillance?

You don’t need to overreact to EPA’s draft rule. But you do need to move. Manufacturers who document their exposure profiles and strengthen their controls now will have far more compliance options when EPA’s final rule is published. Those who wait until 2027 will be scrambling in a compressed timeline.

💰 Cost of Non-Action: If EPA restricts phthalic anhydride manufacturing or use, facilities without documented compliance baselines and reformulation plans will face rapid product phase-outs, supply chain disruptions, and potential liability for worker health claims. Early action costs a few thousand dollars in sampling and medical surveillance; late action costs millions in reformulation, supply chain overhaul, and potential litigation.

We Plug In. You Level Up.